Atlas Trials

Evaluation and Validation of Metabolic Markers for the Assessment of CYP3A Activity and Prediction of DDI

Clinical trial NCT02328443 · COMPLETED

Trial details

NCT number
NCT02328443
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2014-01-01
Primary completion
2015-04-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.